Crispr Therapeutics shares owned by Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors
from 13F filings
Historical chart of Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $285k | 4.2k | 68.16 |
2023-12-31 | $309k | 4.9k | 62.59 |
2023-09-30 | $312k | 6.9k | 45.39 |
2023-06-30 | $393k | 7.0k | 56.14 |
2023-03-31 | $312k | 7.1k | 44.16 |
2022-12-31 | $292k | 7.2k | 40.65 |
2022-09-30 | $482k | 7.4k | 65.40 |
2022-06-30 | $553k | 7.4k | 75.03 |
2022-03-31 | $362k | 5.8k | 62.74 |
2021-12-31 | $400k | 5.3k | 75.87 |
2021-09-30 | $444k | 4.0k | 111.81 |
2021-06-30 | $647k | 4.0k | 161.79 |
2021-03-31 | $487k | 4.0k | 121.78 |
2020-12-31 | $393k | 2.6k | 152.92 |
2020-09-30 | $317k | 3.8k | 83.53 |
2020-06-30 | $224k | 3.1k | 73.44 |
2019-12-31 | $231k | 4.0k | 58.48 |
2019-09-30 | $203k | 5.0k | 41.01 |
2019-06-30 | $233k | 5.0k | 47.07 |
2019-03-31 | $206k | 5.9k | 34.92 |
More positions owned by Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors
View all positions for Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors